Transplant Diagnostics Market To Reach $12.15 Billion By 2033

Transplant Diagnostics Market Growth & Trends

The global transplant diagnostics market size is estimated to reach USD 12.15 billion by 2033, registering a CAGR of 7.45% from 2025 to 2033, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

 Request a free sample copy or view report summary: Transplant Diagnostics Market Report

Transplant Diagnostics Market Report Highlights

• Based on test, the molecular assays segment led the market with the revenue share of 41.37% in 2024, owing to its better accuracy, sensitivity, and clinical value in diagnosing graft rejection and guaranteeing donor-recipient compatibility.

• Based on application, the diagnostics dominated the transplant diagnostics industry with the largest revenue share of 70.93% in 2024.

• Based on transplant area, the solid organ transplantation segment dominated the market with a revenue share of 45.63% in 2024, due to the increasing prevalence of chronic and life-threatening conditions such as cardiovascular diseases, liver cirrhosis, chronic kidney disease, and pulmonary disorders.

• Based on end-use, the hospitals and transplant centers segment dominated the transplant diagnostics market in 2024, owing to the rising healthcare expenditure and use of advanced medical devices in these settings.

• The North America transplant diagnostics market held a dominant revenue share of 32.52% in 2024, owing to the availability of well-developed health infrastructure and a high adoption of advanced medical technologies.

Transplant Diagnostics Market Segmentation

Grand View Research has segmented the global transplant diagnostics market based on test, product, application, transplant area, end-use, and region:

Transplant Diagnostics Test Outlook (Revenue, USD Million, 2021 - 2033)

• Molecular Assays

  • PCR-based Molecular Assays

  • Real-time PCR

  • Sequence-based Primer-PCR

  • Sequence-specific Oligonucleotide-PCR

  • Other PCR-based Molecular Assays

• Sequencing-based Molecular Assays

  • Sanger Sequencing

  • Next Generation Sequencing

  • Other Sequencing-based Molecular Assays

• Non-molecular Assays

  • Serological Assays

  • Mixed Lymphocyte Culture Assays

Transplant Diagnostics Product Outlook (Revenue, USD Million, 2021 - 2033)

• Reagents & Consumables

• Instruments

• Software and Services

Transplant Diagnostics Application Outlook (Revenue, USD Million, 2021 - 2033)

• Diagnostic Application

  • Infectious Disease Testing

  • Histocompatibility Testing

  • Blood Profiling

• Research Application

Transplant Diagnostics Transplant Area Outlook (Revenue, USD Million, 2021 - 2033)

• Solid Area Transplantation

  • Kidney Transplantation

  • Liver Transplantation

  • Heart Transplantation

  • Lung Transplantation

  • Pancreas Transplantation

  • Other Organs Transplantation

• Stem Cell Transplantation

• Soft Tissue Transplantation

• Bone Marrow Transplantation

Transplant Diagnostics End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals and Transplant Centers

• Research and Academic Institutes

• Independent Reference Laboratories

Transplant Diagnostics Regional Outlook (Revenue, USD Million, 2021 - 2033)

•  North America

  • U.S.

    • Canada

    • Mexico 

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players in the Transplant Diagnostics Market

• Thermo Fisher Scientific, Inc.

• Illumina, Inc.

• F. Hoffmann La-Roche Ltd

• Abbott

• QIAGEN

• Bruker

• BD (Becton, Dickinson and Company)

• Werfen (Immucor, Inc.)

• Bio-Rad Laboratories, Inc.

• Omixon Inc.